WATERTOWN, Mass., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of ...
Puma’s new Ignite Elevate 2 and Ignite Elevate X have just hit the market, fusing comfort with structure. You’ll see Rickie Fowler, Max Homa, Gary Woodland, and ...
The Phase 2 IGNITE trial showed no beneficial effects on biomarker or clinical efficacy endpoints with treatment of iluzanebart in ALSP patients. Based upon these results, the Phase 2 long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback